News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AlphaRx Inc. (ALRX) Receives SFDA Approval for Topical Arthritis Product



12/10/2007 3:08:00 PM

December 7, 2007, -- AlphaRx (OTCBB:ALRX) received approval from the State FDA of China for Indaflex™, a topical arthritis relief product. Indaflex™ is a topical formulation of Indomethacin that is incorporated in a nanotechnology drug delivery system developed by AlphaRx. Previously, Indaflex™ was approved in Mexico. AlphaRx International Holdings (AIH), the Hong Kong affiliate of AlphaRx, will launch Indaflex™ in 2008, and it is already building a plant in China to produce the drug. More details....

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES